These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18383887)

  • 21. Molecular changes in superficial bladder cancer.
    Vrabie CD; Petrescu A; Waller M
    Rom J Morphol Embryol; 2007; 48(2):131-8. PubMed ID: 17641799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer.
    Mhawech-Fauceglia P; Ali L; Cheney RT; Groth J; Herrmann FR
    J Clin Pathol; 2009 Aug; 62(8):710-4. PubMed ID: 19638542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative histology of papillary tumors of the bladder. Prognostic value].
    Ffrench M; Bryon PA; Bouvier R; Lesbros F
    Pathol Biol (Paris); 1982 Dec; 30(10):827-31. PubMed ID: 6760058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment on: FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.
    Montironi R
    Eur Urol; 2007 Sep; 52(3):768. PubMed ID: 17240042
    [No Abstract]   [Full Text] [Related]  

  • 26. Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis.
    Maesawa C; Ogasawara S; Yashima-Abo A; Kimura T; Kotani K; Masuda S; Nagata Y; Iwaya T; Suzuki K; Oyake T; Akiyama Y; Kawamura H; Masuda T
    J Clin Pathol; 2006 Mar; 59(3):328-30. PubMed ID: 16505288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
    Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
    Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
    Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
    Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopathological characteristics of micropapillary variant of urinary bladder carcinoma].
    Radulović P; Pavić I; Marusić Z; Perić-Balja M; Znaor A; Kraus O; Kruslin B
    Lijec Vjesn; 2008; 130(1-2):1-3. PubMed ID: 18589634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
    Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
    Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters.
    Bal N; Kocer NE; Ertorer ME; Canpolat ET; Kayaselcuk F
    Pathol Res Pract; 2008; 204(10):743-50. PubMed ID: 18597952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of urokinase plasminogen activator receptor in noninvasive and early invasive urothelial papillary neoplasia.
    Vivani C; Magi S; Mazzucchelli R; Bacchiocchi R; Santinelli A; Muzzonigro G; Blasi F; Montironi R; Fazioli F
    Anal Quant Cytol Histol; 2004 Feb; 26(1):15-21. PubMed ID: 15032076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of maspin and Ki-67 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Acikalin D; Oner U; Can C; Acikalin MF; Colak E
    Tumori; 2012; 98(3):344-50. PubMed ID: 22825520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology.
    Leibl S; Zigeuner R; Hutterer G; Chromecki T; Rehak P; Langner C
    APMIS; 2008 Jan; 116(1):27-32. PubMed ID: 18254777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases.
    Gonul II; Poyraz A; Unsal C; Acar C; Alkibay T
    Urol Int; 2007; 78(4):338-44. PubMed ID: 17495493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urothelial carcinoma with abundant myxoid stroma.
    Tavora F; Epstein JI
    Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.